期刊文献+

Expression of the B-Cell Lymphoma/Leukemia 11A Gene in Malignant Hematological Cell Lines through Quantitative Reverse Transcription Polymerase Chain Reaction

Expression of the B-Cell Lymphoma/Leukemia 11A Gene in Malignant Hematological Cell Lines through Quantitative Reverse Transcription Polymerase Chain Reaction
在线阅读 下载PDF
导出
摘要 The B-cell lymphoma/leukemia 11A (BCL11A) gene is essential for normal lymphoid development and has been associated with hematological malignancies. In the current study, the relative expression level of BCL11A in malignant hematological cell lines was evaluated through real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). METHODS The relative expression level of BCLllA mRNA in malignant hematological cell lines was determined through qRT- PCR using SYBR Green I dye. Glyceraldehyde-3-phosphate dehydro- genase was used as the reference gene to confirm the relative expression level of BCL11A gene mRNA. RESULTS The relative expression level of BCL11A mRNA in cell lines from B-cell malignancies was significantly higher compared with that from acute rnyeloid leukemia (P 〈 0.05). Different cell lines with malignant B-cells exhibited a wide range of BCL11A expressions ranging from 27.37 to 93.38. CONCLUSION The overexpression of BCL11A gene mRNA in malignant B-cells might play a role in B-cell lymphoma/leukemia.
出处 《Clinical oncology and cancer researeh》 CAS CSCD 2011年第4期242-246,共5页
关键词 B-cell lymphoma/leukemia 11A (BCL11A) malignantB-cells real-time quantitative reverse transcription-polymerasechain reaction. 逆转录聚合酶链反应 B细胞淋巴瘤 恶性血液病 细胞株 白血病 基因 定量RT-PCR mRNA
  • 相关文献

参考文献16

  • 1Liu P, Keller JR, Ortiz M, et al. Bcll la is essential for normal lymphoid development. Nat Immunol 2003; 4: 525-532.
  • 2Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcll lb. Science 2010; 329: 89-93.
  • 3Huang X, Chen S, Shen Q, et al. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematolo Oncol 2010; 3: 44,.
  • 4Karlsson A, Nordig~rden A, Jensson JI, et al. Bclllb mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. BMC Cancer 2007; 7: 195.
  • 5Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, et al. Evi9 encodes a novel zinc finger protein that physically interacts with BCLe , a known human B - cell proto- oncogene product. Mol Cell Biol 2000; 20: 3178-3186.
  • 6Hystad ME, Myklebust JH, B~ TH, et al. Characterization of early stages of human B cell development by gene expression profiling. J Immunol 2007; 179: 3662-3671.
  • 7Liu H, Ippolito CG, Wall K J, et al. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Molecular Cancer 2006; 5; 18.
  • 8Satterwhite E, Sonoki T, Willis TG, et aI.The BCL11 gene- family : involvement of BCL 1 1 A in lymphoid malignan- cies. Blood 2001; 98: 3413-3420.
  • 9Weniger MA, Pulford K, Gesk S, et al. Gains of the proto- oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 2006; 20: 1880-1882.
  • 10Martin-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-1477.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部